Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Blood|September 4, 2020
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALLYaqi Zhao, Ibrahim Aldoss, Chunxu Qu, et al.
Bone Marrow Transplantation|April 7, 2021
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world dataTalha Badar, Aniko Szabo, Mark Litzow, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab OzogamicinTalha Badar, Aniko Szabo, Martha Wadleigh, et al.
Bone Marrow Transplantation|November 8, 2019
Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosisRohan Gupta, Faizi Jamal, Dongyun Yang, et al.
Transplantation and Cellular Therapy|March 30, 2021
Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage TherapiesIbrahim Aldoss, Dongyun Yang, Monzr M Al Malki, et al.
Blood Advances|December 6, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failureKuo-Kai Chin, Brian J Ball, Yasmin Abaza, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Leukemia|July 25, 2019
Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemiaHuafeng Wang, Dandan Zhao, Le Xuan Nguyen, et al.
JAMA|May 9, 2024
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical TrialElias Jabbour, Hagop M Kantarjian, Ibrahim Aldoss, et al.
Annals of Internal Medicine|February 11, 2020
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical TrialIbrahim Aldoss, Corinna La Rosa, Lindsey R Baden, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Blood|September 4, 2020
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALLYaqi Zhao, Ibrahim Aldoss, Chunxu Qu, et al.
Bone Marrow Transplantation|April 7, 2021
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world dataTalha Badar, Aniko Szabo, Mark Litzow, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab OzogamicinTalha Badar, Aniko Szabo, Martha Wadleigh, et al.
Bone Marrow Transplantation|November 8, 2019
Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosisRohan Gupta, Faizi Jamal, Dongyun Yang, et al.
Transplantation and Cellular Therapy|March 30, 2021
Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage TherapiesIbrahim Aldoss, Dongyun Yang, Monzr M Al Malki, et al.
Blood Advances|December 6, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failureKuo-Kai Chin, Brian J Ball, Yasmin Abaza, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Leukemia|July 25, 2019
Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemiaHuafeng Wang, Dandan Zhao, Le Xuan Nguyen, et al.
JAMA|May 9, 2024
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical TrialElias Jabbour, Hagop M Kantarjian, Ibrahim Aldoss, et al.
Annals of Internal Medicine|February 11, 2020
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical TrialIbrahim Aldoss, Corinna La Rosa, Lindsey R Baden, et al.
Pageof 19